{"editorial":{"content_id":"1e50c7f4-5101-4504-8165-560f4e583bb7","slug":"clinicarx-20261019-6446a3","content_type":"news","title":"Clinicarx上线九周年预发布新一代产品，覆盖1.8万家药房","summary":"Interplayers旗下药学服务管理平台Clinicarx在正式上线九周年之际预发布新一代产品，围绕临床协议、互联设备、PBM/PSP整合和API集成四大方向展开。","body":"Interplayers旗下专注于药学服务管理的平台Clinicarx在正式上线九周年之际，于Abrafarma Future Trends活动上预发布新一代产品。该平台目前覆盖巴西超过1.8万家药房和诊所，拥有超过7.8万名专业用户，累计完成5900万次服务，覆盖超过1600个城市。\n\n据Interplayers医疗健康业务单元经理Jauri Siqueira Jr.介绍，新一代产品分为四个方向：临床协议、互联健康设备、与药品福利计划（PBM）及患者支持计划（PSP）的整合，以及新的API层与医疗系统集成。该计划还预计与巴西统一医疗系统（SUS）基础设施集成。\n\n新一代的核心亮点是临床协议模块，旨在通过结构化流程指导药剂师接诊，是对此前表单工具的升级。首个上线的协议针对体重管理及使用GLP-1受体激动剂患者的随访。糖尿病和高血压也在首批主题之列，路线图计划新增十多个临床旅程，涉及血脂异常、心理健康、补充剂、戒烟、疫苗复查和呼吸系统疾病等。Jauri表示，该模块的商业逻辑是让药房网络建立标准化的照护项目，具备明确的 criteria、步骤和结果。\n\n第二方向是将健康设备接入药学服务。首个旅程涉及连续血糖监测传感器，平台支持设备注册与标准化，并记录首次使用时的辅助应用和患者指导。Jauri称，其逻辑是把设备视为结构化随访旅程的一部分，而非仅在柜台销售的产品。Interplayers计划逐步扩展至智能手表等可穿戴设备，相关数据可纳入病历并用于平台临床旅程。\n\n第三方向是拉近药学服务与PBM和PSP的距离，将签约药房网络接入由工业界构建的照护线路。Jauri介绍，在接诊过程中平台可识别患者对特定项目的资格、完成预注册并整合与治疗相关的福利和优惠券。\n\n第四方向是新的API、webhook和集成架构，允许接诊数据与药房网络及医疗机构使用的其他系统交换。重点项目之一是Clinicarx与巴西国家健康数据网络（RNDS）的集成。Jauri称，通过专用连接器，平台可自动向国家网络通报药房接种的疫苗，减少操作环节，使零售端记录更接近公共健康信息生态。\n\nJauri表示，这些新进展反映了该方案在Interplayers产品组合中更广泛的重新定位：从面向日程和临床程序组织的软件，转变为连接药房、工业界、可及性项目以及公私医疗系统的基础设施层。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["科技","企业动态","行业趋势","br-health"],"content_level":"编辑整理","event_type":"公司动态","audience_tags":[],"event_location":null,"verification_status":"unverified","published_at":"2026-10-19T17:03:33.657Z","display_date":"2026-10-19","source_published_at":null,"source_url":"https://panoramafarmaceutico.com.br/clinicarx-completa-nove-anos-com-lancamentos/","source_name":"Panorama Farmacêutico","source_language":"pt","author_name":"编辑部","risk_level":"medium","risk_flags":["compliance_risk","regulatory_uncertainty"],"opportunity_flags":["partnership_opportunity","market_entry_opportunity"],"trend_signals":["digital_health_integration","pharmacy_service_expansion"]},"intelligence":{"intel_id":"93f62f31-6ef0-4e6d-bc90-322d3fca389f","version":1,"event_type":"产品上线","event_date":null,"main_entities":[{"name":"Clinicarx","role":"Interplayers旗下药学服务管理平台，预发布新一代产品","type":"platform","country":"巴西","normalized_name":null},{"name":"Interplayers","role":"Clinicarx母公司及医疗健康业务拥有方","type":"company","country":"巴西","normalized_name":null},{"name":"Jauri Siqueira Jr.","role":"Interplayers医疗健康业务单元经理，介绍新一代产品方向","type":"person","country":"巴西","normalized_name":null},{"name":"巴西统一医疗系统（SUS）","role":"计划集成的基础设施","type":"government_body","country":"巴西","normalized_name":null},{"name":"巴西国家健康数据网络（RNDS）","role":"计划通过专用连接器集成，用于药房疫苗接种自动通报","type":"platform","country":"巴西","normalized_name":null}],"main_action":"Clinicarx预发布新一代平台，聚焦临床协议、设备互联、PBM/PSP整合与API集成。","key_numbers":[{"unit":"周年","label":"上线周年","value":"9"},{"unit":"家","label":"覆盖药房和诊所数","value":"1.8万+"},{"unit":"名","label":"专业用户数","value":"7.8万+"},{"unit":"次","label":"累计服务次数","value":"5900万"},{"unit":"个","label":"覆盖城市数","value":"1600+"},{"unit":"个","label":"路线图新增临床旅程计划","value":"10+"}],"facts":[{"verified":false,"statement":"Clinicarx在正式上线九周年之际，于Abrafarma Future Trends活动上预发布新一代产品。","source_excerpt":null},{"verified":false,"statement":"Clinicarx目前覆盖巴西超过1.8万家药房和诊所，拥有超过7.8万名专业用户，累计完成5900万次服务，覆盖超过1600个城市。","source_excerpt":null},{"verified":false,"statement":"新一代产品包括临床协议、互联健康设备、PBM/PSP整合、新API层与医疗系统集成四个方向。","source_excerpt":null},{"verified":false,"statement":"首个临床协议针对体重管理及使用GLP-1受体激动剂患者的随访；糖尿病和高血压也在首批主题之列。","source_excerpt":null},{"verified":false,"statement":"Clinicarx计划通过专用连接器与RNDS集成，自动向国家网络通报药房接种的疫苗。","source_excerpt":null},{"verified":false,"statement":"Interplayers计划逐步扩展至智能手表等可穿戴设备，并将相关数据纳入病历和临床旅程。","source_excerpt":null}],"assessments":[{"statement":"Clinicarx的新一代产品表明其从日程和临床程序管理软件向连接药房、工业界、可及性项目及公私医疗系统的基础设施层转型。","confidence":"high","basis_fact_index":null},{"statement":"临床协议与设备互联有望提升药房在慢病随访、体重管理和GLP-1用药管理中的服务标准化能力。","confidence":"medium","basis_fact_index":null},{"statement":"PBM/PSP整合和API层可能为药房网络带来更多工业界项目和支付方合作机会。","confidence":"medium","basis_fact_index":null},{"statement":"与SUS/RNDS的集成若实施，将涉及健康数据治理和公共系统对接的合规要求。","confidence":"medium","basis_fact_index":null}],"actions":[{"target":"both","priority":"high","description":"跟踪Clinicarx新一代产品的正式上线时间、定价和商业化条款。"},{"target":"both","priority":"high","description":"核验与SUS/RNDS、PBM/PSP及设备厂商的合作协议和数据合规安排。"},{"target":"user","priority":"normal","description":"监测Interplayers在巴西药房数字化和患者支持计划领域的后续合作或并购动向。"}],"affected_audience":["药房和诊所","药剂师","患者","PBM/PSP运营方","医疗设备厂商","制药企业"],"risk_flags":["compliance_risk","regulatory_uncertainty"],"opportunity_flags":["partnership_opportunity","market_entry_opportunity"],"trend_signals":["digital_health_integration","pharmacy_service_expansion"],"follow_up_needed":true,"follow_up_questions":["新一代产品的正式上线日期和商业发布范围是什么？","与SUS/RNDS集成的具体时间表、数据合规和审批安排如何？","PBM/PSP整合已有哪些工业界或支付方合作伙伴？","互联设备（连续血糖监测、智能手表）的数据如何纳入病历并满足巴西健康数据合规要求？"],"related_topics":["药学服务","临床协议","GLP-1随访","连续血糖监测","PBM/PSP","RNDS","SUS","健康数据互操作","药房数字化"],"verification_status":"unverified","confidence_score":0.7,"generated_at":"2026-10-19T17:03:52.894Z"},"meta":{"canonical_url":"https://chinabrazilinsight.com/news/clinicarx-20261019-6446a3","api_url":"https://chinabrazilinsight.com/api/public/content/clinicarx-20261019-6446a3","markdown_url":"https://chinabrazilinsight.com/api/public/content/clinicarx-20261019-6446a3?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/clinicarx-20261019-6446a3?view=json","last_updated":"2026-10-19T17:03:53.036Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}